Meta Information
ID:omega-7
Name:
Schema Version:AIM-2.0
Interactions
Target id:
/dietary/meal
Target name:
Any Caloric Meal
Severity:
major
Interaction type:
requirement
Nature:
temporal
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Omega-7 fatty acids are fat-soluble and require dietary fat to stimulate bile release for proper emulsification and absorption in the small intestine.
Actionable advice:
Always take your omega-7 supplement with a meal that contains some fat for optimal absorption.
Target id:
/class/anticoagulants-antiplatelets
Target name:
Anticoagulants and Antiplatelets
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Omega-7 fatty acids may possess mild antiplatelet properties, which could add to the effects of anticoagulant or antiplatelet medications, theoretically increasing the risk of bleeding or bruising.
Actionable advice:
Consult your doctor before combining; monitor for signs of increased bleeding or bruising.
Target id:
/class/antidiabetic-medications
Target name:
Diabetes Medications
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Omega-7s, particularly palmitoleic acid, may improve insulin sensitivity and lower blood glucose levels, potentially enhancing the effects of diabetes medications and increasing the risk of hypoglycemia (low blood sugar).
Actionable advice:
Monitor blood glucose levels closely when starting or adjusting the dose and consult your healthcare provider.
Target id:
/procedure/surgery
Target name:
Upcoming Surgery
Severity:
major
Interaction type:
adverse
Nature:
temporal
Temporal spacing:
Hours before target:
336
Hours after target:
null
Description:
The potential for increased bleeding risk due to omega-7's possible antiplatelet effects necessitates stopping the supplement well before any surgical procedure to allow platelet function to normalize.
Actionable advice:
Discontinue use at least 2 weeks prior to any scheduled surgery and inform your surgeon.
Target id:
/condition/bleeding-disorders
Target name:
Bleeding Disorders
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Due to potential antiplatelet effects, omega-7 supplements could exacerbate bleeding tendencies in individuals with pre-existing bleeding disorders like hemophilia or von Willebrand disease.
Actionable advice:
Avoid use if you have a bleeding disorder, unless specifically approved by a hematologist.
Target id:
/class/bile-acid-sequestrants
Target name:
Bile Acid Sequestrants
Severity:
moderate
Interaction type:
diminishing
Nature:
temporal
Temporal spacing:
Hours before target:
1
Hours after target:
4
Description:
Bile acid sequestrants (e.g., cholestyramine) can bind to fatty acids and fat-soluble nutrients in the gut, preventing their absorption and reducing the effectiveness of the supplement.
Actionable advice:
Take omega-7 at least 1 hour before or 4 hours after taking a bile acid sequestrant.
Target id:
/intervention/orlistat
Target name:
Orlistat (Fat Absorption Inhibitor)
Severity:
major
Interaction type:
diminishing
Nature:
temporal
Temporal spacing:
Hours before target:
2
Hours after target:
2
Description:
Orlistat works by blocking the absorption of dietary fats, including supplemental fatty acids like omega-7, which would render the supplement ineffective if taken together.
Actionable advice:
Separate your omega-7 dose from orlistat by at least 2 hours.
Target id:
/class/statins
Target name:
Statins (HMG-CoA Reductase Inhibitors)
Severity:
minor
Interaction type:
synergistic
Nature:
absolute
Temporal spacing:
null
Description:
Omega-7s may help lower triglycerides and C-reactive protein (CRP), complementing the lipid-lowering and anti-inflammatory actions of statin medications.
Actionable advice:
May be taken together to support cardiovascular health; inform your doctor to monitor lipid panels.
Target id:
/class/glucose-lowering-supplements
Target name:
Glucose-Lowering Supplements
Severity:
minor
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Combining omega-7s with other supplements that lower blood sugar (like berberine or alpha-lipoic acid) may have an additive effect, increasing the risk of hypoglycemia.
Actionable advice:
Be cautious when combining with other glucose-lowering supplements and monitor for symptoms of low blood sugar.
Target id:
/class/antihypertensives
Target name:
Antihypertensive Medications
Severity:
minor
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Some evidence suggests fatty acids can have a modest blood pressure-lowering effect, which could be additive with antihypertensive medications, potentially leading to hypotension (low blood pressure).
Actionable advice:
Monitor blood pressure when starting or changing your dose, especially if you are on blood pressure medication.
Target id:
/condition/pregnancy
Target name:
Pregnancy
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
The safety of high-dose omega-7 supplementation during pregnancy has not been established, and its effects on fetal development are unknown.
Actionable advice:
Avoid supplementation during pregnancy unless specifically advised by your obstetrician.
Target id:
/condition/lactation
Target name:
Breastfeeding (Lactation)
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
It is unknown if supplemental omega-7 fatty acids are excreted into breast milk in significant amounts or what their effects on a nursing infant might be.
Actionable advice:
Avoid supplementation while breastfeeding due to a lack of safety data.
Target id:
/biomarker/lipid-panel
Target name:
Lipid Panel
Severity:
minor
Interaction type:
synergistic
Nature:
absolute
Temporal spacing:
null
Description:
Omega-7 supplementation is intended to beneficially alter lipid profiles, often by reducing triglycerides and increasing HDL-C, which will be reflected in lab results.
Actionable advice:
Inform your physician you are taking omega-7s when interpreting lipid panel results.
Target id:
/biomarker/hs-crp
Target name:
hs-CRP
Severity:
minor
Interaction type:
synergistic
Nature:
absolute
Temporal spacing:
null
Description:
The anti-inflammatory properties of palmitoleic acid can lead to a reduction in high-sensitivity C-reactive protein (hs-CRP), a marker of systemic inflammation.
Actionable advice:
Expect potential reductions in hs-CRP levels, which should be considered when tracking inflammation.
Target id:
/biomarker/hemoglobin-a1c
Target name:
Hemoglobin A1c
Severity:
minor
Interaction type:
synergistic
Nature:
absolute
Temporal spacing:
null
Description:
By improving insulin sensitivity, omega-7s may lead to lower fasting glucose and subsequently lower HbA1c levels over time.
Actionable advice:
Regular monitoring of glucose and HbA1c is recommended to track therapeutic effects, especially in pre-diabetes or diabetes.